BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10638195)

  • 1. [The role of apolipoprotein E in the pathogenesis of Alzheimer disease].
    Okuizumi K
    Nihon Rinsho; 1999 Dec; 57(12):2673-7. PubMed ID: 10638195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.
    Lahiri DK; Sambamurti K; Bennett DA
    Neurobiol Aging; 2004; 25(5):651-60. PubMed ID: 15172744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
    Richey PL; Siedlak SL; Smith MA; Perry G
    Biochem Biophys Res Commun; 1995 Mar; 208(2):657-63. PubMed ID: 7695621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
    Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apolipoprotein E4 and late-onset Alzheimer's disease].
    Tamaoka A
    Nihon Rinsho; 1994 Dec; 52(12):3257-65. PubMed ID: 7853720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
    Kamboh MI
    Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
    Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
    Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies.
    Nalbantoglu J; Gilfix BM; Bertrand P; Robitaille Y; Gauthier S; Rosenblatt DS; Poirier J
    Ann Neurol; 1994 Dec; 36(6):889-95. PubMed ID: 7998776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E and Alzheimer disease.
    Huang Y
    Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for Alzheimer's disease].
    Yanagisawa K
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1225-7. PubMed ID: 11464462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease.
    Zubenko GS; Stiffler S; Stabler S; Kopp U; Hughes HB; Cohen BM; Moossy J
    Am J Med Genet; 1994 Sep; 54(3):199-205. PubMed ID: 7810577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E as vascular risk factor in neurodegenerative dementia.
    Folin M; Baiguera S; Conconi MT; Di Liddo R; De Carlo E; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2004 Oct; 14(4):609-13. PubMed ID: 15375590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoE genotype accounts for the vast majority of AD risk and AD pathology.
    Raber J; Huang Y; Ashford JW
    Neurobiol Aging; 2004; 25(5):641-50. PubMed ID: 15172743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
    Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.
    Xu PT; Li YJ; Qin XJ; Scherzer CR; Xu H; Schmechel DE; Hulette CM; Ervin J; Gullans SR; Haines J; Pericak-Vance MA; Gilbert JR
    Neurobiol Dis; 2006 Feb; 21(2):256-75. PubMed ID: 16198584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression.
    Butters MA; Sweet RA; Mulsant BH; Ilyas Kamboh M; Pollock BG; Begley AE; Reynolds CF; DeKosky ST
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1075-81. PubMed ID: 14677138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E in the brain and its role in Alzheimer's disease.
    Poirier J
    J Psychiatry Neurosci; 1996 Mar; 21(2):128-34. PubMed ID: 8820179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.